Investing in Biotech is a Long Game: Schulman

Feb.26 -- Polaris Partners Managing Partner Amy Schulman says that the key to investing in biotech is to diversify by investing in a portfolio. She cautions that biotech investments can be risky, but says the successes are spectacular. She joins David Westin on "Bloomberg Wall Street Week."